Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Amira Pharmaceuticals
company
About
Amira Pharmaceuticals is a small molecule pharmaceutical company focused on the discovery and early development of new drugs to treat
- 11 - 50
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $25M
- Industries
- Biotechnology,Health Care,Medical,Pharmaceutical
- Founded date
- Feb 1, 2005
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Amira Pharmaceuticals is a small molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory disease. Their discovery team is building on unparalleled insights into bioactive lipid pathways and complex signaling processes controlling many conditions including asthma, chronic obstructive pulmonary disease, cardiovascular and fibrotic diseases.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$32M
Amira Pharmaceuticals has raised a total of
$32M
in funding over 2 rounds. Their latest funding was raised on
Mar 23, 2007 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 23, 2007 | Series B | $25M | 1 | — | — | Detail |
| Nov 1, 2006 | Series A | $4M | 1 | — | — | Detail |
| Aug 10, 2005 | Series A | $3M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Amira Pharmaceuticals is funded by 1 investors.
Versant Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Versant Ventures
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
